Ata I. Orazvaliev

Ata I. Orazvaliev

Auto-generated profile, based on publicly available information

Ata I. Orazvaliev

ГБУЗ «Городская клиническая больница им. Ф.И. Иноземцева» ДЗМ

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
AMA. E. Markarov
A. E. Markarov
DED. A. Eremin
D. A. Eremin
AOA. I. Orazvaliev
A. I. Orazvaliev
AMA. V. Martirosov
A. V. Martirosov
NKN. M. Krasnov
N. M. Krasnov
ARA. A. Reut
A. A. Reut
Research objective. To stratify the main purulent-inflammatory diseases of maxilla-facial region (PID MFR) by frequencies and limits. To assess mortality in PID MFR. To determine the number of patients with PID MFR and concomitant diabetes mellitus.Resources and Methods. Medical documentation on 9550 patients with PID MFR hospitalized at F.I. Inozemtsev Municipal Clinical Hospital have been analyzed.Research results. The prevalence of purulent-inflammatory diseases remains at a fairly high level. PID MFR occur more often in people of young, able-bodied, age, 18–44 years. The introduction of quarantine measures due to the new coronavirus infection COVID-19 led to an increase in severe forms of PID MFR. There is a decrease in lethality from PID MFR.

1 January 2022 in Russian Rhinology
Verified
Journal Article
Closed access
AMA.A. Makarov
A.A. Makarov
AOA.I. Orazvaliev
A.I. Orazvaliev
RUR.V. Ushakov
R.V. Ushakov
EZE.V. Zhabko
E.V. Zhabko
В статье представлен анализ литературы, посвященной развитию мукормикоза у пациентов с новой коронавирусной инфекцией (COVID-19). Описан случай рино-орбито-церебрального мукормикоза, возникшего на фоне COVID-19 с острым началом заболевания. Приведены результаты лечения пациента с мукормикозом на разных этапах, данные фотопротокола и специальных методов исследования (компьютерная томография). Обоснована важность раннего применения междисциплинарного подхода к диагностике и лечению мукормикоза рино-орбитального комплекса.

28 February 2023 in Russian Journal of Dentistry
Verified
Journal Article
Closed access
PDF file
AMArnold E. Markarov
Arnold E. Markarov
MNMaxim V. Naumenko
Maxim V. Naumenko
AOAta I. Orazvaliev
Ata I. Orazvaliev
DDDmitriy V. Dubov
Dmitriy V. Dubov
EZEfim V. Zhabko
Efim V. Zhabko
BACKGROUND: Complications characterized by necrosis of the nasal mucosa and the hard palate, as well as the middle and lower nasal concha with exposure of the alveolar process, destruction of the posterior wall of the maxillary sinus and the bottom of the orbit caused by a fungal infection were noted during the COVID-19 pandemic. By January 2022, such cases had been documented in 18 countries worldwide. The main predisposing factors for this condition are diabetes mellitus and inadequate use of corticosteroids. Rhinocerebral mucormycosis or zygomycosis is a rare disease caused by filamentous fungi affecting the nose, paranasal sinuses, and brain. AIM: To present the treatment strategy for patients with deep mycoses of the maxillofacial region against a background of transferred COVID-19 in the State Clinical Hospital named after F.I. Inozemtsev DZM. MATERIAL AND METHODS: Fifteen patients with a cerebral form of mucormycosis of the maxillofacial region arose against a background of a new coronavirus infection associated with SARS-CoV-2. RESULTS: The study shows the importance of timely initiation of radical surgical treatment for the rhinocerebral form of mucormycosis in the maxillofacial region, which arose against the background of SARS-CoV-2, to prevent the spread of osteomyelitic foci in bone tissue. CONCLUSION: Early diagnosis of mucormycosis, timely treatment with antipsychotic medications and surgical intervention, control of the level of glycemia, and reasonable use of corticosteroids prevented the development of complications.

13 January 2023 in Medical alphabet
Verified
Journal Article
Open access
PDF file
ДЕД. А. Еремин
Д. А. Еремин
АОА. И. Оразвалиев
А. И. Оразвалиев
АМА. В. Мартиросов
А. В. Мартиросов
EPE. Pakhomova
E. Pakhomova
INI. Nikolskaya
I. Nikolskaya
ДШД. П. Шевницын
Д. П. Шевницын
The paper describes two clinical cases of treatment of patients with noma. This disease is extremely rare in the Russian Federation, and therefore its diagnosis causes difficulties, and incorrect routing of patients, due to diagnostic mistakes, leads to an increase in the time before the start of specialized care. Rapid progression of wet gangrene, in the absence of timely diagnosis and qualified treatment, leads to extensive defects of the maxillofacial region, severe intoxication, sepsis. In the first case, after surgical treatment of noma, the patient developed an extensive tissue defect of the left half of the face, which in the future will require reconstructive surgical treatment. In the second case, after surgical treatment, the patient had an extensive tissue defect in the middle zone of the face, and systemic disorders against the background of intoxication led to the death of the patient on the 7th day after hospitalization. Both clinical cases confirm the role of immunosuppression in the etiology of noma.